Investigations on the molecular dosimetry of tobacco-specific N-nitrosamines.
Approaches for assessing molecular dosimetry of 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN) in humans by measurement of haemoglobin or DNA adducts are discussed. NNK and NNN form haemoglobin adducts in Fischer 344 rats. Acid or base hydrolysis of the globin gives 4-hydroxy-1-(3-pyridyl)-1-butanone, which can be detected in rat blood up to six weeks after injection of NNK; it may be a useful marker for assessing uptake and metabolic activation of NNK and NNN in tobacco consumers. NNK and its major metabolite, 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanol (NNAI), methylated DNA of rat liver, lung and nasal mucosa to similar extents. NNAI is formed in human tissues from NNK, but immunoassays for O6-methyldeoxyguanosine (O6-medGuo) in exfoliated oral cells from snuff-dippers have been negative. NNK is also expected to form pyridyloxobutyl adducts in DNA; 32P-postlabelling assays for these adducts are being developed and appear to hold promise for detecting NNK- or NNN-DNA adducts in vivo.
Hecht
S S
SS
Division of Chemical Carcinogenesis, Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, NY 10595.
Carmella
S G
SG
Trushin
N
N
Foiles
P G
PG
Lin
D
D
Rubin
J M
JM
Chung
F L
FL
D000818:Animals; D004247:DNA / Q000187:drug effects; D006147:Guanine / Q000031:analogs & derivatives / Q000032:analysis; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008099:Liver / Q000032:analysis; D008168:Lung / Q000032:analysis; D009152:Mutagenicity Tests; D009297:Nasal Mucosa / Q000032:analysis; D009602:Nitrosamines / Q000009:adverse effects* / Q000032:analysis; D010947:Plants, Toxic; D051381:Rats; D014026:Nicotiana / Q000032:analysis*; D014030:Tobacco, Smokeless
D006454:Hemoglobins; D009602:Nitrosamines; D006147:Guanine; C008450:7-methylguanine; C016583:4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; D004247:DNA; C008449:O-(6)-methylguanine; C008655:N'-nitrosonornicotine